BRAF and fibrosarcoma: Genetic testing of the postmortem lung tumor and metastatic lymph node tissues revealed not only the EML4‐ALK fusion but also a previously unknown in‐frame acyl glycerol kinase to B‐rapidly accelerated fibrosarcoma (AGK‐BRAF) gene fusion.